How Do You Get Vulvovaginal Candidiasis?
Vulvovaginal candidiasis develops when the normal balance between vaginal Candida colonization and the host environment is disrupted by physiological or behavioral factors, with antibiotic use being the single most important modifiable risk factor, followed by hormonal changes and diabetes 1.
Primary Risk Factors
Host-Related (Physiological) Factors
The most significant predisposing conditions include:
- Antibiotic use - Ranks as the highest risk factor by disrupting normal vaginal flora 2
- Diabetes mellitus - Particularly when uncontrolled; women with diabetes have nearly 3-fold increased odds (aOR = 2.93) 3
- Pregnancy - Hormonal changes during pregnancy substantially increase susceptibility 4, 1
- Immunosuppression - Including HIV infection (especially with lower CD4+ counts) 5, 1
- Hormone replacement therapy - Estrogen-related changes alter vaginal environment 1
- Glucocorticoid use - Systemic steroids increase risk 1
Behavioral and Lifestyle Factors
- Oral contraceptive use - Hormonal contraception modifies vaginal pH and immunity 1
- Sexual intercourse - Ranked second among patient-reported triggers 2
- Humid weather/climate - Creates favorable environment for yeast overgrowth 2
- Feminine hygiene products - Can disrupt normal vaginal flora 2
- Intrauterine devices, spermicides, and condoms - May alter vaginal environment 1
Important Clinical Context for a 50-Year-Old Woman
For a healthy 50-year-old woman specifically, consider:
- Perimenopausal/menopausal status - Hormonal fluctuations during this transition can increase susceptibility 6
- Presence of children under 18 - Associated with 3-fold increased odds (aOR = 3.14), possibly reflecting lifestyle factors 3
- Being part of a couple - Nearly 3-fold increased odds (aOR = 2.86), likely related to sexual activity 3
- Frequent healthcare visits - Women with more healthcare encounters have higher VVC rates (aOR = 2.72) 3
Critical Pitfalls
Idiopathic episodes are extremely common - A surprisingly high number of women report "no known cause" for their VVC episodes, and this occurs similarly in both sporadic and recurrent cases 2. This means that even with careful history-taking, you may not identify a clear trigger in many patients.
The distinction between estrogen-dependent VVC and estrogen-independent cutaneous candidiasis matters - At age 50, particularly if perimenopausal or postmenopausal, consider whether symptoms represent true VVC versus cutaneous candidiasis, as these have different pathogenesis and management 6.
Epidemiological Reality
VVC affects 70-75% of women during their lifetime 5, with an incidence rate of 3.3 per 1000 person-years for first episodes 7. Approximately 50% will have at least a second episode, and up to 10% develop recurrent VVC 7. The infection is caused by Candida albicans in 85-95% of cases 4, though non-albicans species (particularly C. glabrata) are increasingly recognized 1, 8.